HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of aluminum hydroxide adjuvant on the immunogenicity of the 2009 pandemic influenza A/H1N1 vaccine: multi-level modeling of data with repeated measures.

AbstractOBJECTIVE:
To evaluate the effect of the aluminum hydroxide (Al-OH) adjuvant on the 2009 pandemic influenza A/H1N1 (pH1N1) vaccine.
METHODS:
In a multicenter, double-blind, randomized, placebo-controlled trial, participants received two doses of split-virion formulation containing 15 μg hemagglutinin antigen, with or without aluminum hydroxide (Al-OH). We classified the participants into six age categories (>61 years, 41-60 years, 19-40 years, 13-18 years, 8-12 years, and 3-7 years) and obtained four blood samples from each participant on days 0, 21, 35, and 42 following the first dose of immunization. We assessed vaccine immunogenicity by measuring the geometric mean titer (GMT) of hemagglutination inhibiting antibody. We used a two-level model to evaluate the fixed effect of aluminum Al-OH and other factors, accounting for repeated measures.
RESULTS:
The predictions of repeated measurement on GMTs of formulations with or without Al-OH, were 80.35 and 112.72, respectively. Al-OH significantly reduced immunogenicity after controlling for time post immunization, age-group and gender.
CONCLUSION:
The Al-OH adjuvant does not increase but actually reduces the immunogenicity of the split-virion pH1N1 vaccine.
AuthorsDa Peng Yin, Bao Ping Zhu, Hua Qing Wang, Lei Cao, Wen Di Wu, Ke Yu Jiang, Wei Xia, Guo Min Zhang, Jing Shan Zheng, Ling Sheng Cao, Xiao Feng Liang
JournalBiomedical and environmental sciences : BES (Biomed Environ Sci) Vol. 24 Issue 6 Pg. 624-9 (Dec 2011) ISSN: 0895-3988 [Print] China
PMID22365398 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Adjuvants, Pharmaceutic
  • Antibodies, Viral
  • Influenza Vaccines
  • Aluminum Hydroxide
Topics
  • Adjuvants, Pharmaceutic (chemistry)
  • Adolescent
  • Adult
  • Aluminum Hydroxide (chemistry)
  • Antibodies, Viral (blood)
  • Child
  • Child, Preschool
  • China
  • Data Interpretation, Statistical
  • Double-Blind Method
  • Female
  • Hemagglutination Inhibition Tests
  • Humans
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza Vaccines (adverse effects, chemistry, immunology)
  • Influenza, Human (epidemiology, immunology, prevention & control, virology)
  • Male
  • Middle Aged
  • Models, Statistical
  • Pandemics
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: